Enanta Pharmaceuticals, Inc.
Sales Per Share
| Fiscal Year | Sales Per Share |
|---|---|
| FY2016 | $4.59 |
| FY2017 | $5.30 |
| FY2018 | $10.01 |
| FY2019 | $9.79 |
| FY2020 | $6.14 |
| FY2021 | $4.81 |
| FY2022 | $4,181.92 |
| FY2023 | $3,777.19 |
| FY2024 | $3,196.81 |
| FY2025 | $3,061.68 |
Sales Per Share
| Fiscal Year | Sales Per Share |
|---|---|
| FY2016 | $4.59 |
| FY2017 | $5.30 |
| FY2018 | $10.01 |
| FY2019 | $9.79 |
| FY2020 | $6.14 |
| FY2021 | $4.81 |
| FY2022 | $4,181.92 |
| FY2023 | $3,777.19 |
| FY2024 | $3,196.81 |
| FY2025 | $3,061.68 |